Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tighiouart

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biometrics|December 29, 2000
Bayesian estimators for conditional hazard functionsI W McKeague, M Tighiouart
British Journal of Cancer|November 13, 2008
Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinomaH Zhang, L Su, S Müller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2019
Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiationZ S Zumsteg, M Luu, S Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2018
Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiationZ S Zumsteg, M Luu, S Kim, et al.
British Journal of Cancer|January 17, 2013
A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignanciesR D Harvey, T K Owonikoko, C M Lewis, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biometrics|December 29, 2000
Bayesian estimators for conditional hazard functionsI W McKeague, M Tighiouart
British Journal of Cancer|November 13, 2008
Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinomaH Zhang, L Su, S Müller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2019
Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiationZ S Zumsteg, M Luu, S Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2018
Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiationZ S Zumsteg, M Luu, S Kim, et al.
British Journal of Cancer|January 17, 2013
A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignanciesR D Harvey, T K Owonikoko, C M Lewis, et al.
Pageof 1